Bruce Car - Jan 5, 2025 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Role
Chief Scientific Officer
Signature
/s/ George Clark, Attorney-in-Fact
Stock symbol
BHVN
Transactions as of
Jan 5, 2025
Transactions value $
-$90,070
Form type
4
Date filed
1/7/2025, 08:51 PM
Previous filing
Jun 20, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHVN Common Shares Options Exercise $0 +4.75K +199.33% $0.00 7.13K Jan 5, 2025 Direct
transaction BHVN Common Shares Tax liability -$90.1K -2.33K -32.68% $38.64 4.8K Jan 5, 2025 Direct F1
holding BHVN Common Shares 30K Jan 5, 2025 By IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Stock Options (Right to buy) Award $0 +112K $0.00 112K Jan 5, 2025 Common Shares 112K $38.64 Direct F2
transaction BHVN Restricted Share Unit Award Award $0 +19K $0.00 19K Jan 5, 2025 Common Shares 19K Direct F3, F4, F5
transaction BHVN Restricted Share Unit Award Options Exercise $0 -4.75K -25% $0.00 14.3K Jan 5, 2025 Common Shares 4.75K Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
F2 The shares underlying this option vest in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service with the Issuer at each vesting date.
F3 Each restricted share unit represents the contingent right to receive one common share of the Issuer.
F4 The reporting person was granted 19,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date.
F5 Not applicable.